IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 231 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $343,194 | -75.8% | 35,638 | -73.2% | 0.01% | -76.2% |
Q2 2023 | $1,416,195 | +1.5% | 133,101 | +0.4% | 0.02% | -4.5% |
Q1 2023 | $1,394,868 | -11.7% | 132,592 | +4.0% | 0.02% | -15.4% |
Q4 2022 | $1,578,957 | +60.0% | 127,438 | +33.8% | 0.03% | +36.8% |
Q3 2022 | $987,000 | +258.9% | 95,276 | +299.5% | 0.02% | +280.0% |
Q2 2022 | $275,000 | +11.3% | 23,850 | +21.2% | 0.01% | +25.0% |
Q1 2022 | $247,000 | +6.9% | 19,672 | -0.9% | 0.00% | 0.0% |
Q4 2021 | $231,000 | 0.0% | 19,852 | +12.4% | 0.00% | -20.0% |
Q3 2021 | $231,000 | +35.1% | 17,657 | +32.9% | 0.01% | +66.7% |
Q2 2021 | $171,000 | +15.5% | 13,289 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $148,000 | -2.0% | 13,289 | 0.0% | 0.00% | -25.0% |
Q4 2020 | $151,000 | +55.7% | 13,289 | +23.3% | 0.00% | +33.3% |
Q3 2020 | $97,000 | -12.6% | 10,780 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $111,000 | – | 10,780 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |